Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
04/22/2009 | CN101415683A New compounds |
04/22/2009 | CN101413143A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
04/21/2009 | US7521563 Hydroxamic acid derivative and medicine containing the same as active ingredient |
04/21/2009 | US7521467 Administering phenolic derivatives including 6-methoxy-2,3-benzoxazolinone (6-MBOA), benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides; antiarthritic, antidiabetic, and hypoglycemic agents; sleep disorders, fibromyalgia; monocotyledon plant extracts |
04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
04/16/2009 | WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
04/16/2009 | WO2009048874A1 Method of making ketals and acetals |
04/16/2009 | WO2009047797A2 Process for the preparation of perhydroisoindole derivative |
04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
04/16/2009 | WO2009027998A3 A process for the preparation of alanine-nca (alanine-n-carboxyanhydride) from alanine with tri phosgene |
04/16/2009 | WO2007034254A3 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
04/16/2009 | US20090099355 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids |
04/16/2009 | US20090099233 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
04/16/2009 | US20090099201 Diacylglycerol Acyltransferase Inhibitors |
04/16/2009 | US20090099189 CRTH2 Receptor Ligands For Medicinal Uses |
04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
04/16/2009 | CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
04/16/2009 | CA2701519A1 Piperidine and piperazine derivatives |
04/15/2009 | EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
04/15/2009 | CN101410385A Benzothiazoles having histamine H3 receptor activity |
04/15/2009 | CN101410384A Compounds and methods for modulating protein trafficking |
04/15/2009 | CN101410375A Method for producing aromatic compound |
04/15/2009 | CN101410373A Bridged cyanine compounds and optical recording materials containing the same |
04/15/2009 | CN101407501A Preparation of 5-methyl morpholine-3-amino-2-oxazolidinone derivative hapten, antigen and antibody |
04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
04/14/2009 | CA2138533C Drugs that enhance synaptic responses mediated by ampa receptors |
04/09/2009 | WO2009043889A2 Oxadiazole derivatives |
04/09/2009 | WO2009004141A3 Method for preparing enantiomerically enriched n-carboxyanhydride |
04/09/2009 | US20090093497 Diacylglycerol Acyltransferase Inhibitors |
04/09/2009 | US20090093451 IL-8 Receptor Antagonists |
04/09/2009 | US20090091252 Binaphthyl compound and organic light emitting element using the same |
04/09/2009 | US20090091234 Room temperature molten salt and display element |
04/09/2009 | CA2696863A1 Oxadiazole derivatives |
04/08/2009 | EP2045238A1 Bridged cyanine compounds and optical recording materials containing the same |
04/08/2009 | EP2044040A2 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents |
04/08/2009 | EP2044010A1 New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof |
04/08/2009 | CN101405278A Novel heterocyclic NF-kB inhibitors |
04/08/2009 | CN101402603A Polyhalogenated heterocycle ketene peptide derivative and synthesis thereof |
04/08/2009 | CN100475872C Azlactone chain transfer agents for free radical polymerization |
04/08/2009 | CN100475799C Merocyanine derivatives for cosmetic use |
04/08/2009 | CN100475795C Heterocyclic compounds useful as nurr-1 activators |
04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
04/07/2009 | CA2490152C Oxazole derivatives and their use as insulin sensitizers |
04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
04/02/2009 | WO2009043027A2 Multi-armed forms of activated polyoxazoline and methods of synthesis thereof |
04/02/2009 | WO2009040008A1 Novel iminooxazole and iminothiazole compounds |
04/02/2009 | WO2009021749A3 Preparation of a compound for the treatment of duchenne muscular dystrophy |
04/02/2009 | WO2009021748A3 Polymorphs of a compound for the treatment of duchenne muscular dystrophy |
04/02/2009 | WO2009011880A3 Heterocyclic modulators of pkb |
04/02/2009 | WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders |
04/02/2009 | US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease |
04/01/2009 | EP2042492A1 Novel Iminooxazole and Iminothiazole Compounds |
04/01/2009 | EP1755585A4 Transthyretin stabilization |
04/01/2009 | CN101397279A Method for preparing acanthus alkaloid A with anti inflammatory and analgesic activities and derivatives thereof |
04/01/2009 | CN101397278A Method for synthesizing 3-aryl-5-alkenyl oxazoline-2-one |
03/31/2009 | US7511156 Analogs of Salinosporamide A |
03/31/2009 | US7511149 Using ruthenium tetraoxide and alkali metal permanganate |
03/31/2009 | US7511068 antiinflammatory agents |
03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
03/26/2009 | WO2009015111A3 Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates |
03/26/2009 | US20090082395 Soluble epoxide hydrolase inhibitors |
03/26/2009 | US20090082392 Substituted Carboxylic Acids |
03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
03/25/2009 | EP2039689A1 Process for production of optically active 3-amino-2 -hydroxypropionic cyclopropylamide derivatives and salts thereof |
03/25/2009 | EP2038265A2 Human protein tyrosine phosphatase inhibitors and methods of use |
03/25/2009 | EP1789403B1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl.succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator activated receptors) for the treatment of hyperlipidaemie and diabetes |
03/25/2009 | CN100471838C VLA-4 inhibitors |
03/24/2009 | US7507830 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles |
03/24/2009 | US7507757 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
03/19/2009 | WO2009035951A2 Soluble epoxide hydrolase inhibitors |
03/19/2009 | WO2008139467A3 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses |
03/19/2009 | US20090076280 N-(benzoxazole-2-yl)-N-(3-(4-methoxyphenoxy)propyl)-3-hydroxybenzylamine dissolved in dichloromethane and triethylamine is reacted with 2-trifluoromethanesulfonyloxybutyrolactone to form (R)-2-[3-[N-(benzoxazol-2-yl)-N-(3-(4-methoxyphenoxy)propyl)aminomethyl]phenyloxy]butyrolactone |
03/19/2009 | US20090076102 Deuterium-enriched muraglitazar |
03/19/2009 | US20090076006 Hsp90 inhibitors containing a zinc binding moiety |
03/19/2009 | US20090075979 CETP Inhibitors |
03/19/2009 | US20090075938 Treatment of duchenne muscular dystrophy |
03/18/2009 | EP2035397A1 Chemical compounds |
03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
03/18/2009 | CN101389684A Curable epoxy resin composition |
03/18/2009 | CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
03/17/2009 | US7504515 IMPDH inhibitor useful in treating IMPDH-mediated diseases such as immune system related diseases, viral diseases, and cancers |
03/17/2009 | US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents |
03/17/2009 | US7504426 Antiallergens; rhitinis; antiinflammatory agents |
03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
03/12/2009 | WO2009032294A2 Processes for the preparation of a linezolid intermediate, linezolid hydroxide |
03/12/2009 | WO2009030672A1 Process for the manufacture of alkyl compounds |
03/12/2009 | US20090069396 Polyene Oxazoles and Processes for Their Preparation |
03/12/2009 | US20090069330 Substituted Oxazole Compounds with Analgesic Activity |
03/12/2009 | US20090066245 Material for light-emitting element and light emitting element |
03/11/2009 | EP2033957A1 Process for the manufacture of alkyl compounds |
03/11/2009 | EP2033950A1 Substituted tetracycline compounds |
03/11/2009 | EP2032546A1 Oxazole derivatives and their use in the treatment of diabetes and obesity |
03/11/2009 | EP2032535A1 Spirocyclic nitriles as protease inhibitors |
03/11/2009 | EP1620440B1 Synthesis of substituted heterocyclic compounds |
03/11/2009 | CN101384563A Substituted oxazole derivatives with an analgesic action |
03/11/2009 | CN101384532A Process for preparing optically active alcohols |
03/11/2009 | CN100467466C Intermediate products for producing oxazolidinone-quinolone hybrids |
03/11/2009 | CN100467456C Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist |